UPDATE 2-Roche seeks EU nod on Tarceva cancer drug,stock up
617687
Roche (ROG.VX: Quote, Profile, Research) has filed for EU marketing approval for its Tarceva drug to treat advanced non-small cell lung cancer, the Swiss healthcare group said on Thursday, boosting its shares.
378747
Swiss pharmaceutical company Roche Holding AG said Friday that a European Union body had moved toward possible approval this year of the cancer drug Avastin.
652440
The FTSE 100 has climbed as a surge by US shares gives a boost to European markets. Shire Pharmaceuticals SHP.L jumped after winning approval for a key drug and consumer goods giant Unilever ULVR.
630746
Genentech Inc. and Swiss drug maker Roche Holding AG said Monday that a recent study showed their colon cancer drug Avastin significantly extended patient survival when combined with an oxaliplatin-based chemotherapy drug.
328806
Shares of Protein Design Labs Inc (PDLI.O: Quote, Profile, Research) rose on Thursday after Swiss drugmaker Roche Holding AG (ROG.
152243
Shares in BiogenIdec (BIIB:Nasdaq - news - research) and Elan (ELN:NYSE - news - research)rose early Monday after the companies released what they described as &quot;compelling&quot; phase III test results for their multiple sclerosis drug Antegren.
185638
Swiss drug giant Roche said Monday that its Tarceva drug improves the results of chemotherapy in prolonging the lives of patients with advanced pancreatic cancer.
112717
The US Food and Drug Administration Friday said it had approved Tarceva (erlotinib) tablets for patients with metastatic lung cancer.
330736
BOSTON -- Nastech Pharmaceutical Co. Inc. stock rose Thursday, apparently on speculation that Merck &amp; Co.&#39;s withdrawal of Vioxx will mean that Merck has to lean more heavily on Nastech for a new blockbuster drug.
235034
BASEL, Switzerland  - Net profit at Roche Holding AG  rose 34 percent to 9.17 billion Swiss francs ($7.33 billion) in 2006 due to strong sales of cancer treatments Herceptin and Avastin, just ahead of analysts' expectations.
327774
Pfizer Inc's experimental drug for a deadly form of stomach cancer has been recommended for so-called orphan drug status in the European Union, the European Medicines Agency said.
397085
Roche said on Monday its influenza medication Tamiflu will be in ample supply during the 2006-2007 flu season in pharmacies across the United States, with more than double the stock available last season.
557014
Adding Herceptin to chemotherapy before surgery eradicates tumors in nearly three times as many women with inflammatory breast cancer as chemotherapy alone, the drug's maker Roche Holding AG said on Wednesday.
476212
On Thursday, biotechnology companies Genentech Inc. and OSI Pharmaceuticals Inc. said US regulators have approved their drug Tarceva for treating the most common form of lung cancer.
26608
German and Swiss drug makers Schering and Novartis are developing a new anti-cancer drug with annual sales potential of up to two billion euros (2.7 billion dollars), Schering chief Hubertus Erlen said.
634298
Shares of Biocryst Pharmaceuticals Inc. (BCRX.O) rose on Tuesday after the company received "orphan drug" status for an anti-cancer compound.
535789
Net profit at Roche Holding  AG  rose 34 percent to 9.17 billion Swiss francs ($7.33  billion) in 2006 due to strong sales of cancer treatments  Herceptin and Avastin, just ahead of analysts' expectations.